Skip to main content

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX )

51.78 +1.11 (+2.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
February 09, 2016
Form 8-K
Source: SEC/Edgar
November 24, 2015
Form 8-K
Source: SEC/Edgar
November 11, 2015
Form 8-K
Source: SEC/Edgar
July 07, 2015
Form 8-K/A
Source: SEC/Edgar
May 11, 2015
Form NT 10-K/A
Source: SEC/Edgar
April 14, 2015
Form 8-K
Source: SEC/Edgar
April 14, 2015
Form NT 10-K
Source: SEC/Edgar
March 30, 2015
Form 8-K
Source: SEC/Edgar
March 29, 2015
Form 8-K
Source: SEC/Edgar
March 16, 2015
Form 8-K
Source: SEC/Edgar
January 25, 2015
Form 8-K
Source: SEC/Edgar
December 23, 2014
Form 10-Q/A
Source: SEC/Edgar
December 11, 2014
Form NT 10-Q
Source: SEC/Edgar
November 13, 2014
Form 8-K
Source: SEC/Edgar
November 13, 2014
Form DEF 14A
Source: SEC/Edgar
October 05, 2014
Form 10-Q/A
Source: SEC/Edgar
September 17, 2014
Form NTN 10Q
Source: SEC/Edgar
August 14, 2014
Form 8-K
Source: SEC/Edgar
July 14, 2014
Form 3/A
Source: SEC/Edgar
June 18, 2014
Form 8-K
Source: SEC/Edgar
June 12, 2014
Form 8-K
Source: SEC/Edgar
June 08, 2014
Form NT 10-Q
Source: SEC/Edgar
May 15, 2014
Form NT 10-K
Source: SEC/Edgar
March 30, 2014
Form CT ORDER
Source: SEC/Edgar
March 24, 2014
Form 8-K
Source: SEC/Edgar
February 09, 2014
Form NT 10-Q
Source: SEC/Edgar
November 14, 2013
Form 8-K
Source: SEC/Edgar
October 09, 2013
Form DEF 14A
Source: SEC/Edgar
August 11, 2013
Form 10-K/A
Source: SEC/Edgar
April 16, 2013
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.